title: Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection.
abstract: Using fresh whole blood or isolated lymphocytes, the activity of in vivo generated cytotoxic T-lymphocytes (CTL) was measured as the OKT3-specific lysis of HL-60 targets, in a cross-sectional study of 53 HIV (+) patients. CTL activity in the entire HIV(+) group was two to three times higher than in HIV(-) controls, with WHO stage 3 (=pre-AIDS) patients showing the highest cytolytic function. The whole-blood CTL assay was validated and its practical and theoretical advantages are discussed. Within the CD8(+) cells, the number and proportion of the CD45RO(+) "memory" subset were significantly increased in HIV(+) subjects. The HLA-DR(+) subset rose most spectacularly in the asymptomatic stage of the infection, while the CD38(+) subset was the only one still significantly rising between the pre-AIDS and the AIDS stage. CTL activity was most closely correlated with T8 cells expressing the CD38 marker. In the context of CTL, CD38 thus seems to reflect activation rather than immaturity. Lymphocytes from HIV(+) subjects with a high OKT3-specific lytic capacity also destroyed normal lymphoblasts to a significant extent, pointing to their possible involvement in an autodestructive process. Our data thus suggest the importance of T8 cytolytic function and/or T8 subtyping in the immunopathogenesis and the prognosis of HIV infection.
authors.affiliation: Laboratory of Pathology & Immunology, Institute of Tropical Medicine, Antwerp, Belgium.
authors.forename: G
authors.initials: G
authors.lastname: Vanham
authors.forename: L
authors.initials: L
authors.lastname: Kestens
authors.forename: G
authors.initials: G
authors.lastname: Penne
authors.forename: C
authors.initials: C
authors.lastname: Goilav
authors.forename: P
authors.initials: P
authors.lastname: Gigase
authors.forename: R
authors.initials: R
authors.lastname: Colebunders
authors.forename: M
authors.initials: M
authors.lastname: Vandenbruaene
authors.forename: J
authors.initials: J
authors.lastname: Goeman
authors.forename: G
authors.initials: G
authors.lastname: van der Groen
authors.forename: J L
authors.initials: JL
authors.lastname: Ceuppens
mesh_terms: D036541:ADP-ribosyl Cyclase; D051997:ADP-ribosyl Cyclase 1; D015703:Antigens, CD; D000943:Antigens, Differentiation; D016827:CD8 Antigens; D003602:Cytotoxicity, Immunologic; D005260:Female; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins; D016853:Muromonab-CD3; D010641:Phenotype; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D015703:Antigens, CD; D000943:Antigens, Differentiation; D016827:CD8 Antigens; D008562:Membrane Glycoproteins; D016853:Muromonab-CD3; D036541:ADP-ribosyl Cyclase; C498154:CD38 protein, human; D051997:ADP-ribosyl Cyclase 1